DC
Defender Capital Portfolio holdings
AUM
$295M
This Quarter Return
-14.02%
1 Year Return
+53.43%
3 Year Return
+101.94%
5 Year Return
+160.32%
10 Year Return
–
AUM
$105M
AUM Growth
–
Cap. Flow
+$105M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
97.41%
Holding
15
New
15
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$25.6M |
| 2 |
Danaher
DHR
|
$19.2M |
| 3 |
STAAR Surgical
STAA
|
$15.2M |
| 4 |
Monster Beverage
MNST
|
$14.5M |
| 5 |
Fortive
FTV
|
$13.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 43.34% |
| 2 | Financials | 24.41% |
| 3 | Consumer Staples | 13.8% |
| 4 | Technology | 12.75% |
| 5 | Consumer Discretionary | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class B
BRK.B
$1.09T
| $25.6M | 24.41% |
+125,488
| New | +$25.6M |
|
|
2
Danaher
DHR
$147B
| $19.2M | 18.3% |
+186,297
| New | +$19.2M |
|
|
3
STAAR Surgical
STAA
$1.36B
| $15.2M | 14.48% |
+476,286
| New | +$15.2M |
|
|
4
Monster Beverage
MNST
$60.9B
| $14.5M | 13.8% |
+294,265
| New | +$14.5M |
|
|
5
Fortive
FTV
$16.2B
| $13.1M | 12.46% |
+193,365
| New | +$13.1M |
|
6
Lineage Cell Therapeutics
LCTX
$267M
| $3.63M | 3.46% |
+3,984,470
| New | +$3.63M |
|
7
Winmark
WINA
$1.65B
| $3.22M | 3.06% |
+20,224
| New | +$3.22M |
|
8
Enovis
ENOV
$1.77B
| $3.12M | 2.97% |
+149,393
| New | +$3.12M |
|
9
Kinder Morgan
KMI
$60B
| $2.36M | 2.25% |
+153,361
| New | +$2.36M |
|
10
Inovio Pharmaceuticals
INO
$126M
| $2.32M | 2.21% |
+581,100
| New | +$2.32M |
|
11
Serina Therapeutics
SER
$54.5M
| $1.38M | 1.31% |
+346,805
| New | +$1.38M |
|
12
Compugen
CGEN
$132M
| $630K | 0.6% |
+290,533
| New | +$630K |
|
13
Amazon
AMZN
$2.44T
| $404K | 0.38% |
+269
| New | +$404K |
|
14
Apple
AAPL
$3.45T
| $302K | 0.29% |
+1,920
| New | +$302K |
|
|
FIT
15
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $0 | ﹤0.01% |
+20,000
| New | – |
|